Janssens Stelara Receives FDA Approval for Treatment of Adults with Crohns Disease

PR Newswire Horsham Pa. September 26 2016 Janssen Biotech Inc. announced today that the U.S. Food and Drug Administration FDA has approved STELARAÂ ustekinumab for the treatment of moderately to severely active Crohns disease in adults 18 years or older w...